Clinical trials for Hemophilia B
18 recruiting or active trials synced from ClinicalTrials.gov.
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data- RECRUITINGPhase 3NCT07285460A Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 1 to Less Than 12 Years With Hemophilia A or BSanofi
- RECRUITINGPhase 3NCT07080905Phase 3, Open-label, Single-dose Study of CSL222 in Adolescent Male Subjects (≥ 12 to < 18 Years of Age) With Severe or Moderately Severe Hemophilia BCSL Behring · PI: Study Director
- RECRUITINGPHASE1, PHASE2NCT06611436BeCoMe-9: A Clinical Study of BE-101 for the Treatment of Adults With Moderately Severe or Severe Hemophilia BBe Biopharma
- ACTIVE NOT RECRUITINGPhase 3NCT06569108Efficacy and Safety of KN057 Prophylaxis in Patients With Haemophilia A or B Without InhibitorsSuzhou Alphamab Co., Ltd. · PI: Renchi Yang, Doctor
- RECRUITINGPhase 3NCT06003387Efficacy and Safety of CSL222 (Etranacogene Dezaparvovec) Gene Therapy in Adults With Hemophilia B With Pretreatment Adeno-associated Virus Serotype 5 (AAV5) Neutralizing Antibodies (Nabs)CSL Behring · PI: Study Director
- RECRUITINGNCT06008938An Observational Cohort Study to Characterize the Effectiveness and Safety of HEMGENIX® in Patients With Hemophilia BCSL Behring · PI: Global Program Director
- RECRUITINGN/ANCT05630651The Efficacy and Safety of ZS801 in Chinese Hemophilia B Patients.Institute of Hematology & Blood Diseases Hospital, China · PI: Lei Zhang, MD
- RECRUITINGPhase 1NCT05709288Gene Therapy for Hemophilia B Patients Aged 12-18 Years OldInstitute of Hematology & Blood Diseases Hospital, China · PI: Lei Zhang, MD
- ACTIVE NOT RECRUITINGPhase 3NCT05662319A Study to Test a Medicine (Fitusiran) Injected Under the Skin for Preventing Bleeding Episodes in Male Adolescent or Adult Participants With Severe HemophiliaSanofi · PI: Clinical Sciences & Operations
- RECRUITINGN/ANCT04817462Liver Biopsy In Haemophilia Gene TherapyUniversity College, London · PI: Paul Batty, MBBS MRCP
- RECRUITINGPHASE1, PHASE2NCT05641610A Study to Evaluate the Safety and Efficacy of ZS801 in Adult Hemophilia B PatientsInstitute of Hematology & Blood Diseases Hospital, China · PI: Lei Zhang, MD
- ACTIVE NOT RECRUITINGPHASE2, PHASE3NCT05203679Evaluation of the Safety and Efficacy of Hemophilia B Gene Therapy DrugShanghai Xinzhi BioMed Co., Ltd. · PI: Lei Zhang, MD
- RECRUITINGEarly Phase 1NCT05152732Safety and Tolerability of VGB-R04 in Patients With Haemophilia BInstitute of Hematology & Blood Diseases Hospital, China · PI: Lei Zhang, Doctor
- RECRUITINGPhase 3NCT05145127Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without InhibitorsPfizer · PI: Pfizer CT.gov Call Center
- ACTIVE NOT RECRUITINGNCT05360706Study of AAV5-hFIX in Severe or Moderately Severe Haemophilia BCSL Behring · PI: Study Director
- ACTIVE NOT RECRUITINGN/ANCT04628871Long Term Follow-up (LTFU) of Subjects Who Received SB-318, SB-913, or SB-FIXSangamo Therapeutics · PI: Medical Monitor, MD
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT01687608Open-Label Single Ascending Dose of Adeno-associated Virus Serotype 8 Factor IX Gene Therapy in Adults With Hemophilia BBaxalta now part of Shire · PI: Study Director
- ACTIVE NOT RECRUITINGPhase 1NCT00979238Dose-Escalation Study Of A Self Complementary Adeno-Associated Viral Vector For Gene Transfer in Hemophilia BSt. Jude Children's Research Hospital · PI: Ulrike Reiss, MD